Pulmonary vaccination as a novel treatment for lung fibrosis.

Pulmonary fibrosis is an untreatable, uniformly fatal disease of unclear etiology that is the result of unremitting chronic inflammation. Recent studies have implicated bone marrow derived fibrocytes and M2 macrophages as playing key roles in propagating fibrosis. While the disease process is characterized by the accumulation of lymphocytes in the lung parenchyma and alveolar space, their role remains unclear. In this report we definitively demonstrate the ability of T cells to regulate lung inflammation leading to fibrosis. Specifically we demonstrate the ability of intranasal vaccinia vaccination to inhibit M2 macrophage generation and fibrocyte recruitment and hence the accumulation of collagen and death due to pulmonary failure. Mechanistically, we demonstrate the ability of lung Th1 cells to prevent fibrosis as vaccinia failed to prevent disease in Rag-/- mice or in mice in which the T cells lacked IFN-γ. Furthermore, vaccination 3 months prior to the initiation of fibrosis was able to mitigate the disease. Our findings clearly demonstrate the role of T cells in regulating pulmonary fibrosis as well as suggest that vaccinia-induced immunotherapy in the lung may prove to be a novel treatment approach to this otherwise fatal disease.
AuthorsSamuel L Collins, Yee Chan-Li, Robert W Hallowell, Jonathan D Powell, Maureen R Horton
JournalPloS one (PLoS One) Vol. 7 Issue 2 Pg. e31299 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22363610 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Bleomycin
  • Interferon-gamma
  • Administration, Intranasal
  • Animals
  • Bleomycin
  • Fibroblasts (pathology)
  • Interferon-gamma (immunology)
  • Lung (immunology, pathology)
  • Lymphocyte Count
  • Macrophages (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Pulmonary Fibrosis (immunology, prevention & control, therapy)
  • Survival Analysis
  • Th1 Cells (immunology)
  • Time Factors
  • Vaccination (methods)
  • Vaccinia virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: